BSX · Boston Scientific Corp.
AI read · Bad for BSX
The AI's read
A Class I recall for the Infinion CX lead, mandatory withdrawal of unused inventory, and 1,081 documented serious injuries create meaningful near-term operational, regulatory, and liability headwinds for Boston Scientific. The recall is limited to un‑implanted inventory and reports note no deaths and no extra surveillance for implanted patients, which partially mitigates longer-term clinical risk but does not erase immediate commercial and legal exposure.